Ascendia Pharmaceutical Solutions announced that the 4th annual two-day technical workshop Advances in Innovative Technologies for Formulation & Delivery of Molecules is scheduled for September 15-16, 2026 at the Crowne Plaza Princeton - Conference Center, featuring Mengqi (Miki) Yu, PhD, leading a discussion on From Lab Innovation to Clinical Proof of Concept: 45% Drug Load Redispersible NanoASD for BCS IV Compounds.

Public source

Publisher name

Public post

Our list of speakers at the Ascendia Pharmaceutical Solutions 4th annual two-day technical workshop, Advances in Innovative Technologies for Formulation & Delivery of Mo…

Log in to read the full post

Company

Ascendia Pharmaceutical Solutions

Making the Impossible Possible

Industry
Pharmaceutical Manufacturing
Location
North Brunswick, US
Company size
51–200 employees

About Ascendia Pharmaceutical Solutions

Based in North Brunswick, New Jersey, Ascendia Pharmaceutical Solutions is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceutical Solutions is your ideal partner for: • Pre-formulation services/screening • Formulation development • Proprietary nanotechnologies • ICH stability studies • Sterile and non-sterile manufacturing • Analytical services, QC and Micro testing • Clinical trial material supply • Niche commercial product manufacturing

See more

Latest activity

7 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.